Search Result "p16INK4a"
Ginsenoside Rg1 Attenuates Premature Ovarian Failure of D-gal InducedPOF Mice Through Downregulating p16INK4a and Upregulating SIRT1Expression
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 22 Issue: 3 Year: 2022 Page: 318-327
Author(s): Xiao-Hu Liu,Shi-Zhong Cai,Yue Zhou,Ya-Ping Wang,Yan-Jun Han,Cui-Li Wang,Wen Zhou
Jun Dimerization Protein 2 in Oxygen Restriction; Control of Senescence
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 2278-2289
Author(s): Shin-Wei Wang, Jiag-Ki Lee, Chia-Chen Ku, Shyh-Shin Chiou, Chen-Lung Steve Lin, Ming-Feng Ho, Deng-Chyang Wu, Kazunari K. Yokoyama
Dissection of Signal Transduction Pathways as a Tool for the Development of Targeted Therapies of Hepatocellular Carcinoma
Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 3 Year: 2007 Page: 217-236
Author(s): Diego F. Calvisi, Rosa M. Pascale, Francesco Feo
HPV Infections: Basis of Neoplastic Transformation and Related Molecular Tests
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 8 Year: 2013 Page: 1371-1378
Author(s): Deborah French,Laura Lorenzon
The 9p21 Locus and its Potential Role in Atherosclerosis Susceptibility; Molecular Mechanisms and Clinical Implications
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 37 Year: 2016 Page: 5730-5737
Author(s): Amir Tajbakhsh,Mohammad Sadegh Khorrami,Seyed Mahdi Hassanian,Malihe Aghasizade,Alireza Pasdar,Mina Maftouh,Ehsan Tabatabai,Seyed Mohammad Reza Parizadeh,Mostafa Fazeli,Gordon A. Ferns,Majid Ghayour-Mobarhan,Amir Avan
microRNAs in Cancer: Lessons from Melanoma
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 33 Year: 2014 Page: 5246-5259
Author(s): Eyal Greenberg,Yael Nemlich,Gal Markel
Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy
Journal: Current Cancer Therapy Reviews
Volume: 2 Issue: 3 Year: 2006 Page: 271-279
Author(s): Yong Wang, Virginia Probin, Daohong Zhou
Diagnostic Tests for the Detection of Human Papillomavirus-associated Cervical Lesions
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 8 Year: 2013 Page: 1358-1370
Author(s): Miriam Reuschenbach,Magnus von Knebel Doeberitz
Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context
Journal: Current Molecular Medicine
Volume: 6 Issue: 7 Year: 2006 Page: 731-738
Author(s): David G. Johnson, James DeGregori
E2F1-Mediated Apoptosis as a Target of Cancer Therapy
Journal: Current Molecular Pharmacology
Volume: 2 Issue: 2 Year: 2009 Page: 149-160
Author(s): Zhenlong Wu, Qiang Yu